SHAREHOLDER NOTICE: Brodsky & Smith Investigates 8i Acquisition 2 Corp. (Nasdaq – LAX)

BALA CYNWYD – April 12, 2022 /Globe Newswire/ – Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of 8i Acquisition 2 Corp. (“8i” or the “Company”) (Nasdaq – LAX) for possible breaches of fiduciary duty and other violations of federal and state law in connection with recent corporate actions, including the Company’s business combination agreement to acquire EUDA Health Limited (“EUDA”), a Singapore-based digital health platform.

The deal involves James Meng Dong Tan on both sides; he is CEO & Chairman of the Board of 8i, and he is a 10% shareholder of Watermark Developments Limited (“Watermark”), the sole shareholder of EUDA. Upon closing, Watermark will own approximately 82% of the combined company’s outstanding ordinary shares and minority shareholders of 8i will see their shares diluted.

If you own shares of 8i and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman, Esquire at Brodsky & Smith, Two Bala Plaza, Suite 805, Bala Cynwyd, PA 19004, or call toll free 877-534-2590.

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.